Evaluation Core

项目概要评价核心 NeuroTech Harbor（NTH）评估核心（EC）是NTH的关键要素。EC将负责 提供全面，及时的评估大量的创新者的建议，并确定那些少数， 具有很高的临床影响和商业可行性潜力。此外，欧洲委员会将确定提案中的差距 帮助创新者改进，并指导未来重新申请NTH或其他BP中心的步骤。欧盟必须 不仅要确保提案中提出的需求是重要的，而且要确保可行的计划是可行的， 为实现可交付成果而制定的计划，包括所需的资源。由于NTH将获得广泛的 申请，欧洲委员会将聘请顶级专家充分评估的建议。最后，欧盟委员会将招募专家 来自不同的背景，这是神经科技港的核心价值。最后，欧盟委员会将评估并提供指导 创新者可以通过扩大其影响力， 服务不足的社区。 为了帮助管理这项复杂的任务，NTH EC将利用改善医学联盟， 创新与技术（CIMIT）的指导和影响跟踪（GAITS）基于网络的平台，以（i）帮助 创新者准备有竞争力的提案，（ii）为所有EC小组提供方法，特别是深度- 潜水小组，以一致的标准评估子项目提案。欧盟委员会将提供申请人和小组 接受过如何使用GAITS平台的基本培训的成员。招聘不同的专家，涵盖以下主题 所有提交的建议，以服务于我们的评估小组，欧洲委员会将与NTH的顾问网络， 利用医疗技术制造加速器The LaunchPort，拥有广泛的多元化专家网络。 欧盟委员会的目标是：（目标1）实施严格、公正和有效的评估过程， 神经医学解决方案具有很高的商业成功和临床效益潜力。(Aim 2）部署一个 建议书管理平台，以便于评估子项目和分包建议书，以及 准备提案。(Aim 3）促进建立一个由不同的有抱负的创新者组成的管道。评价 该过程的灵感来自RADx模型和NIH同行评审系统，将包括行业专家，他们 将评估建议解决方案的整个生命周期的可行性。评估将分三个阶段进行：分类， 生存能力和深度潜水。在筛选期间将评估简短的预提案，并评估完整的提案 在可行性和深潜期间。将使用GAITS标准和NTH的新股权评估完整的提案， 无障碍标准。深入研究阶段将涉及与以下人员的密集互动和多个反馈周期： 提案人和审查人。为便于评估和管理子项目和分合同建议书， NeuroTech Harbor与VentureWell（VW）合作，将为申请者提供一个在线门户网站， 他们的申请，以及来自EC，指导委员会和NIH人员的审查员进行审查和评论 关于提案。

PROJECT SUMMARY EVALUATION CORE NeuroTech Harbor's (NTH) Evaluation Core (EC) is a critical element of the NTH. The EC will be responsible for providing thorough, timely evaluations of a large number of innovator proposals and identify those few that have a high potential for clinical impact and commercial viability. In addition, the EC will identify gaps in proposals that help innovators improve, as well as guide future steps on reapplying to NTH or other BP Hubs. The EC must not only ensure that the need addressed in a proposal is significant, but also that a feasible plan is viable and laid out to achieve deliverables, including resources required. Since NTH will receive a broad range of applications, the EC will recruit top experts to adequately evaluate proposals. Finally, the EC will recruit experts from diverse backgrounds, a core value of NeuroTech Harbor. Lastly the EC will assess and provide guidance in ways innovators can increase the potential for commercial success globally by expanding their impact to under-served communities. To help manage this complex task, the NTH EC will leverage the Consortia for Improving Medicine with Innovation & Technology's (CIMIT's) Guidance and Impact Tracking (GAITS) web-based platform to (i) help innovators prepare competitive proposals, and (ii) provide a methodology for all EC panels, especially the Deep- Dive panel, to assess subproject proposals with consistent criteria. The EC will provide applicants and panel members with basic training on how to use the GAITS platform. To recruit diverse specialists covering topics of all submitted proposals to serve on our evaluation panels, the EC will work with NTH's Consultant Network, and leverage The LaunchPort, a MedTech manufacturing accelerator, with an extensive network of diverse experts. The EC aims are: (Aim 1) To implement a rigorous, unbiased, and efficient evaluation process that identifies neuromedical solutions with high potential for commercial success and clinical benefit. (Aim 2) To deploy a proposal management platform to facilitate evaluation of subproject and subaward proposals as well as preparation of proposals. (Aim 3) To facilitate building a pipeline of diverse aspiring innovators. The evaluation process is inspired by the RADx model and the NIH peer review system and will include industry experts who will appraise the feasibility of the total lifecycle of proposed solutions. Evaluation will occur in three stages: Triage, Viability, and Deep Dive. Short preproposals will be evaluated during Triage, and full proposals will be evaluated during Viability and Deep Dive. Full proposals will be assessed using GAITS criteria and NTH's new equity & accessibility criteria. The Deep Dive stage will involve intensive interaction and multiple feedback cycles with proposers and reviewer. To facilitate evaluation and management of subproject and subaward proposals, NeuroTech Harbor, in partnership with VentureWell (VW), will provide an online portal for applicants to submit their applications and for reviewers from the EC, Steering Committee, and NIH personnel to review and comment on proposals.